Advertisement
Advertisement
U.S. markets open in 6 hours 41 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Nektar Therapeutics (NKTR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
3.0000+0.0500 (+1.69%)
At close: 04:00PM EST
3.0100 +0.01 (+0.33%)
After hours: 07:20PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Performance Outlook
Previous Close2.9500
Open3.0000
Bid0.0000 x 1300
Ask0.0000 x 800
Day's Range2.8606 - 3.0300
52 Week Range1.9900 - 11.5900
Volume2,067,743
Avg. Volume1,660,181
Market Cap563.862M
Beta (5Y Monthly)0.92
PE Ratio (TTM)N/A
EPS (TTM)-2.6640
Earnings DateFeb 27, 2023 - Mar 03, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.41
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NKTR

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Nektar Therapeutics
    NKTR: What does Argus have to say about NKTR?NEKTAR THERAPEUTICS has an Investment Rating of SELL; a target price of $2.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
Advertisement
Advertisement